Clinical Trial Update: Use of the Medical Device DECAP CO2 for the Treatment of Hypercapnic Respiratory Distress in Patients Under Noninvasive Ventilation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the DECAP CO2 medical device for treating hypercapnic respiratory distress in patients on noninvasive ventilation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercapnia
• Respiratory Distress Syndrome

Drugs mentioned

• DECAP CO2

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Respiratory Distress Syndrome, Hypercapnia | Phase 2 | Status: UNKNOWN